A trust reaping the rewards of the healthcare revival
After a long period in the doldrums, the biotechnology sector is staging a comeback. A more benign interest…
Private Investor’s Diary: Three strategies that are paying off
If February marked the divergence of global equities from the US, March saw geopolitical events take centre stage.…
An oversold US healthcare giant that’s now a bargain
Ideally, a value stock will have a clear reason for its recent devaluation, a strong balance sheet and…
This scaled-up wealth manager looks unjustifiably cheap
Consolidation in the UK wealth management sector is being accelerated by competition-driven fee and cost pressures, the rise…
This overhyped tech stock is no longer an AI play – Investors' Chronicle
This overhyped tech stock is no longer an AI play Investors’ ChronicleForecast: here’s what £20,000 in Palantir stock could…
This market leader is going from strength to strength
Ask a friend what springs to mind at the mention of ‘self storage’, and the chances are it…